10-Q: Quarterly report
8-K: Ensysce Biosciences Reports Third Quarter 2024 Financial Results
SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.9%),Peter Kolchinsky(9.9%), etc.
SC 13G: Statement of acquisition of beneficial ownership by individuals-Perceptive Advisors LLC(8.7%),Joseph Edelman(8.7%), etc.
8-K: Current report
DEFA14A: Others
EFFECT: Others
DEF 14A: Definitive information statements
ARS: Annual Report to Security Holders
EFFECT: Others
DEL AM: Others
S-3: Registration statement for specified transactions by certain issuers
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
PRE 14A: Preliminary proxy statements relating to merger or acquisition
D: Filing D
8-K: Current report
424B5: Prospectus
424B5: Prospectus
8-K: Current report
8-K: Ensysce Biosciences Reports Second Quarter 2024 Financial Results
No Data
No Data